CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » Breast Cancer

RESEARCH REPORT 

Omega-3 Fatty Acids Shown to Prevent Breast Cancer Growth

By Anna Azvolinsky, PhD1 | March 14, 2013
1Freelance Science Writer and Cancer Network Contributor. Follow Her on Twitter

Researchers have demonstrated that mammary tumor development can be directly inhibited by lifelong exposure to n-3 polyunsaturated fatty acid (PUFA) in mice. The study, published in the Journal of Nutritional Biochemistry, directly shows the anticancer activity of omega-3s. David Ma, PhD, associate professor at the University of Guelph and colleagues used an aggressive mouse breast cancer model that overexpressed HER2 to understand the long-term effect of omega-3s on breast cancer growth and development.

In a purely genetic approach to study the effect of omega-3 fatty acids on tumor development, the breast cancer model mice were crossed with mice harboring the fat-1 transgene to create a hybrid mouse model. The fat-1 transgene encodes for an enzyme that is able to endogenously convert n-6 PUFA to n-3 PUFA. The hybrid fat-1 breast cancer model mice had 30% smaller tumor volumes compared to their control counterparts that did not express the fat-1 gene. “Using this mouse model we show that it is the presence/absence of omega-3 fatty acids that was associated with tumor size and numbers,” said Ma.

In a different set of experiments using the breast cancer mouse model, mice were either fed a steady diet that included n-3 polyunsaturated fatty acids (n-3 PUFA) or same diet but without n-3 PUFA. The omega-3 fed mice also had 30% lower tumor volumes compared to the mice that ate a regular diet without n-3 PUFA.

Ma says that he did not anticipate a dramatic effect of the dietary fatty acid because the mouse model used develops breast cancer very aggressively. “I thought the aggressive nature of the cancer may overshadow any potential benefit of the omega-3s, but given that we are able to observe a benefit in this aggressive model, which is a HER2-positive breast cancer model, we have even greater confidence that the benefit is real,” said Ma. Using both a conventional diet and a genetic approach gave the researchers confidence that the omega-3s truly play a role in breast cancer prevention.

Both the genetically engineered and the mice fed an n-3 PUFA diet had similar numbers of tumors develop, about 3.5 per mouse compared to 5.5 tumors in control mice that neither harbored the fat-1 gene nor were exposed to n-3 PUFA in their diet. The reduction in number of tumors was statistically significant. No differences in the time to first detectable tumor were found for any of the mice.

The evidence that omega-3 fatty acids have a role in cancer prevention has been mixed. Direct causal effects from epidemiological studies linking dietary nutrients are difficult due to many confounding variables. For breast cancer, there have been inconsistent findings in humans on the effect of omega-3 fatty acids. Ma points out that these inconsistencies are mainly related to the challenging nature of nutrition research where careful consideration of lifelong dietary intake is needed but difficult to measure. Many confounding variables related to lifestyle and environment also contribute to equivocal results. “Teasing out the effect of one specific component from food and showing a cause-effect relationship is difficult,” said Ma,

To get around these challenges, the current research was essentially a nutrition experiment but using a modern genetic approach without having to manipulate the diet, said Ma.

Next Steps

“The present study examined the simple question of how lifelong exposure affects development,” said Ma. Ma and colleagues are now actively engaged in expanding their research to determine whether there is a critical window of mammary gland development that is most important for cancer prevention. Because the mammary glands develops during discrete periods in the womb, during puberty, and pregnancy/lactation, there may be critical times when environmental and biological factors play important roles in cancer development.

While Ma and colleagues are not working on studying the effect of omega-3 fatty acids on other cancer development, there is evidence that omega-3 fatty acids may help prevent colon and prostate cancers, as well as skin cancer. Ma would like this research to lead to more studies on how dietary components can reduce cancer risk and boost a healthier lifestyle. "I believe this study provides evidence that we should consider omega-3s as part of a healthy balanced diet to enhance the quality of our life and reduce the severity of cancer in those diagnosed with the disease.”

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.






 
RELATED CONTENT

50 Shades of Pink—And Why It Helps to Know the Difference
May 17, 2013
It’s Time for Clinicians to Reconsider Their Proscription Against the Use of Soyfoods by Breast Cancer Patients
ONCOLOGY,  May 13, 2013
HERA Trial: Invasive Lobular Breast Carcinoma Patients Derived Same Benefit From Trastuzumab Maintenance
May 7, 2013
PIK3CA Mutations Negatively Affect Survival in Trastuzumab-Treated HER2-Positive Breast Cancer
May 6, 2013
US Task Force Recommends Breast Cancer Medications for High-Risk Women
April 24, 2013
 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
   SEARCH MEDICA RX
   Browse drugs by name:
A B C D E F G H I J
K L M N O P Q R S T
U V W X Y Z All      
   Search for drugs:
Search

 

 
FROM PHYSICIANS PRACTICE
Primary Care Can't Thrive Without Nurse Practitioners
Courtney H. Lyder, ND,  May 17, 2013
With a projected shortfall of primary-care physicians, it's time for alternate solutions to patient care. Nurse practitioners are one logical remedy.
VWhat Physicians Can Learn from the Allscripts EHR Lawsuit
Marisa Torrieri,  May 16, 2013
Lawsuit prompts question: What should physicians do to ensure they end up with a great EHR instead of buyer’s remorse?
Eight Ways ICD-9 Will Still Matter to Medical Practices
Brenda Edwards, CPC,  May 15, 2013
What should your medical practice do with your ICD-9-CM book after October 1, 2014? Keep it.
Seven Ways Technology Can Speed Up Patient Collections
Cheyenne Brinson,  May 15, 2013
Failing to adopt widely available billing and collections technology can cost medical practices big. Here's how to do it right.
Four Reasons Private Medical Practice is Becoming Extinct
Carol Stryker,  May 15, 2013
It’s becoming increasingly difficult for private medical practices to thrive. Here’s what’s driving the trend toward consolidation.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Skin Lesions
  • Colorectal Lesions
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • Colorectal Lesions
  • New AUA Guidelines for Prostate Cancer Screening
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • Genomics Studies Identify Testicular Cancer Risk Variants
  • Lower Back Pain in an Elderly Man With a History of Localized Prostate Cancer
  • FDA Approves Erlotinib (Tarceva) as First-Line Lung Cancer Therapy for Certain Patients
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • “This Is My Last Day on Earth”
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Patient Quality of Life Endpoints in Oncology Trials, Part II
  • Who's Coding Whom?
  • “How Do I Say This Nicely? Your Oncologist Wasn't Following Guidelines”
  • Cancer Metabolism as a Therapeutic Target
  • Study: Cholesterol Drugs Reduced Risk of Prostate Cancer Death
  • “This Is My Last Day on Earth”
  • ONS: Safe Handling of Chemotherapy
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
Click here to subscribe to our newsletter



CancerNetwork on Facebook
 
SearchMedica SEARCH RESULTS

Find peer-reviewed literature and websites for practicing medical professionals

CME on Breast Cancer
Evidence on Breast Cancer
Guidelines on Breast Cancer
Patient Education on Breast Cancer
Clinical Trials on Breast Cancer
Practical Articles on Breast Cancer
Research and Reviews on Breast Cancer
All "Breast Cancer" results

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy